Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Accured Expenses (2017 - 2026)

Inspire Medical Systems' Change in Accured Expenses history spans 10 years, with the latest figure at -$12.3 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 24.47% to -$12.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.1 million, a 13.05% increase, with the full-year FY2025 number at $6.1 million, down 52.41% from a year prior.
  • Change in Accured Expenses hit -$12.3 million in Q1 2026 for Inspire Medical Systems, down from $6.6 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for INSP hit a ceiling of $13.7 million in Q4 2024 and a floor of -$16.3 million in Q1 2025.
  • Historically, Change in Accured Expenses has averaged $1.5 million across 5 years, with a median of $4.5 million in 2022.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 126.99% in 2022 and later soared 105.35% in 2023.
  • Tracing INSP's Change in Accured Expenses over 5 years: stood at $4.9 million in 2022, then soared by 105.35% to $10.1 million in 2023, then surged by 35.38% to $13.7 million in 2024, then tumbled by 51.44% to $6.6 million in 2025, then crashed by 285.82% to -$12.3 million in 2026.
  • Business Quant data shows Change in Accured Expenses for INSP at -$12.3 million in Q1 2026, $6.6 million in Q4 2025, and $10.8 million in Q3 2025.